Projects per year
Organisation profile
We undertake clinical trials and clinical research in areas of Respiratory Medicine and Rhinology and ENT Surgery, with an emphasis on Asthma, Interstitial Lung Disease and disorders altering the sense of smell. Currently the group co-ordinates three National Clinical Trials with funding totalling £6.3M. The ARRISA-UK project is investigating the role of risk registers and their implementation in clinical practice, the EME-TIPAC study is investigating the efficacy of antibiotic therapy in people with idiopathic pulmonary fibrosis and the MACRO study is evaluating the effects of macrolide treatment in people with chronic rhino sinusitis. We also undertake studies looking at epidemiology, health related quality of life, exercise, and biomarkers, in a range of conditions affecting the respiratory tract in its widest sense.
Our key areas of research are:
- Interstitial Lung Disease
- Asthma
- Smell
- Rhinitis and rhino sinusitis
- Biomarkers
- Exercise and activity
Collaborations and top research areas from the last five years
Profiles
-
Eleanor Mishra
- Norwich Medical School - Honorary Senior Lecturer
- Respiratory and Airways Group - Member
Person: Honorary, Research Group Member
-
Carl Philpott
- Norwich Medical School - Professor of Rhinology & Olfactology
- Lifespan Health - Member
- Respiratory and Airways Group - Member
Person: Academic, Teaching & Scholarship, Research Group Member, Research Centre Member
-
Exploring supportive and palliative care in pulmonary fibrosis
Norfolk & Norwich University Hospitals NHS Foundation Trust
1/11/23 → 30/06/24
Project: Research
-
-
Engaging Users in Smell Self-Care at Home
Engineering and Physical Sciences Research Council
1/10/22 → 30/09/24
Project: Research
-
A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO)
Kumaresan, K., Bengtsson, S., Sami, S., Clark, A., Hummel, T., Boardman, J., High, J., Sobhan, R. & Philpott, C., 12 Oct 2023, In: Pilot and Feasibility Studies. 9, 174.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Downloads (Pure) -
Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
Jegatheeswaran, L., Gokani, S. A., Luke, L., Klyvyte, G., Espehana, A., Garden, E. M., Tarantino, A., Al Omari, B. & Philpott, C. M., 4 Aug 2023, In: Frontiers in Neuroscience. 17, 1165329.Research output: Contribution to journal › Review article › peer-review
Open AccessFile -
Changes in exhaled volatile organic compounds following indirect bronchial challenge in suspected asthma
Peel, A., Wang, R., Ahmed, W., White, I., Wilkinson, M., Loke, Y. K., Wilson, A. M. & Fowler, S. J., Oct 2023, In: Thorax. 78, 10, p. 966-973 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure)
Prizes
-
-
Bronze Clinical Excellence Award
Philpott, Carl (Recipient), 2019
Prize: Prize (including medals and awards)
-
Silver Clinical Excellence Award (ACCIA)
Philpott, Carl (Recipient), Mar 2023
Prize: National/international honour
Activities
-
BOARS Meeting/ENT UK Research Showcase
Carl Philpott (Speaker)
15 Sep 2023Activity: Participating in or organising an event › Participation in conference
-
UK Semiochemistry Meeting
Carl Philpott (Speaker)
4 Jul 2023 → 5 Jul 2023Activity: Participating in or organising an event › Participation in workshop or seminar
-
29th Congress of the European Rhinologic Society
Carl Philpott (Speaker)
20 Jun 2023Activity: Participating in or organising an event › Participation in conference
Press/Media
-
-
Research priorities for smell disorders revealed
6/05/22
1 item of Media coverage
Press/Media: UEA Press Release
-
How does one recover from long Covid symptoms? (Apr 2022)
5/03/22 → 14/03/22
6 items of Media coverage
Press/Media: Press / Media